Every product evaluation, formulation critique, and clinical condition guide published on Clinical Derma Lab is strictly reviewed by board-certified medical doctors and certified cosmetic chemists to meet Google's rigorous YMYL healthcare standards.
Zero Commercial Brand Sponsorships: Our laboratory purchases all cosmetic formulations at standard retail price. No skincare conglomerate provides gifted samples, free testing batches, or editorial pre-approval.
•
Physician Sign-Off Requirement: No review or diagnostic condition monograph is published without primary author credential verification and final signature from our Chief Medical Officer.
•
Continuous Biannual Audits: Product formulations are audited every 6 months to account for unannounced manufacturer reformulations, preservation changes, and active ingredient dilutions.
AT
Dr. Aris Thorne, MD, FAAD
Chief Medical Officer & Board-Certified Dermatologist
Dr. Thorne is a double board-certified clinical dermatologist and Associate Clinical Professor with over 16 years of academic and hospital experience. He completed his residency at Johns Hopkins and specializes in cutaneous biophysics, barrier dysregulation, and photodermatology.
✓American Board of Dermatology (ABD) Diplomate
✓Fellow, American Academy of Dermatology (FAAD)
✓Member, American Society for Dermatologic Surgery (ASDS)
Director of Cosmetic Chemistry & Formulation Science
Dr. Rostova holds a doctorate in Macromolecular Physical Chemistry and has spent 14 years formulating emulsions and nano-delivery systems. She oversees our HPLC compound quantification, emulsion stability centrifugal testing, and pH equilibrium analysis.
✓PhD in Macromolecular Chemistry
✓Fellow, Society of Cosmetic Chemists (SCC)
✓Specialist in Lipid Bilayer Emulsion Stability
✓Author of 18 Peer-Reviewed Dermocosmetic Papers
MV
Dr. Marcus Vance, MD
Dermatopathologist & Clinical Research Fellow
Dr. Vance provides cellular-level insights using in-vivo reflectance confocal microscopy and epidermal biopsy analysis. His research focuses on folliculocentric inflammation, contact sensitization cascades, and non-comedogenic bio-assays.
✓Board-Certified in Anatomic Pathology & Dermatopathology
✓Fellow, American Society of Dermatopathology (ASDP)
✓Pioneer in In-Vivo Follicular Laser Imaging
✓Clinical Investigator for Irritant Contact Dermatitis
Rigorous Editorial Quality
Our 4-Stage Medical Peer Review Protocol
To eliminate confirmation bias and guarantee clinical accuracy, every product report navigates a sequential 4-stage pipeline before publication.
1
In-Vitro Screening
Formulation decomposition, active ingredient concentration assay via HPLC, and initial preservative system stability test.
2
Biometric Testing
Volunteer cohort testing evaluating TEWL reduction with Tewameter hex-probes, Corneometer hydration, and follicular biopsies.
3
Meta-Analysis
Statistical cross-correlation with longitudinal real-world patient data (tolerance rates, irritation flags, and adverse event logs).
4
Physician Sign-Off
Final editorial audit by Dr. Aris Thorne, MD, FAAD, ensuring statements align with current AAD dermatological treatment guidelines.
Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. Journal of the American Academy of Dermatology (JAAD), 2006;55(3):490-500.
Katta R, Desai SP. Diet and dermatology: the role of dietary intervention in skin disease. Journal of Clinical and Aesthetic Dermatology (JCAD), 2014;7(7):46-51.
